Latest filing published 03 Dec 2020 for Oncopeptides AB, €13k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Marty Duvall: trading record in brief
Marty Duvall discloses dealings in Oncopeptides AB to Finansinspektionen. In total, 2 filings cover trades dated from 15 September 2020 to 1 December 2020.
Purchases make up the whole of the open-market record (2 purchases, €115k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 3 December 2020: an open-market purchase of €13k, in Oncopeptides AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Marty Duvall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 800 shares@ SEK 160.10AktieISIN SE0009414576FI:csv-03334dd7f6f796bea42cCanonical exit: 1 Mar 2021 (T+90)
- 8,000 shares@ SEK 133.90AktieISIN SE0009414576FI:csv-cdf8dbccb63a3dc95cb4Canonical exit: 14 Dec 2020 (T+90)
2 of 2 declarations